London, Mar 7 : Researchers from University of Birmingham have identified a protein that appears to play a key role in forming blood clots.

Small cells called platelets circulate in the blood and respond to injury by becoming sticky and sending out tiny "arms" that latch onto other platelets and the surface of the injury, forming a clot.

Lead researcher Yotis Senis claim to have identified a protein called CD148 that controls the stickiness of blood.

London, March 7: A study on 650 English people suggest that patients with type 2 diabetes are given medication too soon, instead of being recommended to eat better and do more exercise.

London, Mar 7 : Water that boosts memory, chocolates that fight acne, black pepper-flavoured chewing gum - these are some of the bizarre "future foods" that could soon hit market shelves in the UK.

Experts have searched the entire world to find the food and drink products likely to make it big in the UK in the coming months.

Among the strange snacks are chocolate bars made with smoked bacon from the US.

A selection of the new goods will make their UK debut at a food and drink show in London next weekend.

One of the products on show is bottled water marketed as a way of sharpening the memory. The American drink called Y Brain Water is enriched with vitamins and minerals, reports The Daily Express.

Washington, Mar 7: Forcing your kid to eat cold, mushy veggies may do more harm than good, according to a new study.

According to a research from Cornell University, although parents have good intentions about forcing their kids to finish their broccoli, this approach may backfire the very next day.

Washington, Mar 7: A diet high in vegetable intake can reduce the risk of prostate cancer (CaP), says a new study.

In the online edition of Molecular Nutrition and Food Research, Ruth Chan and collaborators suggested that the primary mechanism of the protective vegetable effect is antioxidant protection against DNA and cell damage.

Literature, which was already available, was identified for the study. Of the available studies, 29 were cohort studies,
69 case-control studies, and 4 randomised clinical trials.

Washington, March 6 : A vaginal microbicide gel has for the first time shown some promise to prevent HIV infection in women in a clinical trial involving more than 3,000 subjects in the U. S. and southern Africa.

While making a presentation on the trial's findings at the Conference on Retroviruses and Opportunistic Infections (CROI), the researchers said that one 0.5 per cent dose of a microbicide designed to prevent HIV from attaching to cells in the genital tract, was 30 per cent effective.